Pregnancy

  • App launches new mode tackling pregnancy loss and mental health

    Currently, one in five women experience perinatal mental health disorders like depression and anxiety, yet 50 per cent go undiagnosed. Now, hormone-tracking app, Moody, is aiming to address the issue with the launch of its new mode that supports mothers through metal health crises, pregnancy and pregnancy loss. Pregnancy loss affects one in four pregnancies, [...]

  • Pre-eclampsia associated with earlier onset of cardiovascular risk factors

    Women who have experienced pre-eclampsia have accelerated accumulation of cardiovascular (CV) risk factors compared with women who had pregnancies without pre-eclampsia according to new research. Pre-eclampsia typically affects 2 to 5 per cent of pregnant women and is broadly defined as the development of hypertension and high protein levels in the urine of a woman [...]

  • Postpartum hormonal contraceptive use and risk of depression

    A new study has revealed that hormonal contraceptive initiation postpartum was associated with an instantaneous increased risk of developing depression. The study set out to investigate whether taking hormonal contraceptive (HC) post partum is associated with the risk of developing depression within 12 months after delivery. Findings from the study of 610 038 first-time mothers [...]

  • Transforming postpartum diabetes screening with new glucose tolerance test

    New research suggests that a shorter, one-hour glucose tolerance test outperforms the standard two-hour test in predicting future risk of postpartum diabetes and could transform clinical practice. Pregnancy acts as a stress test that can indicate a woman’s predisposition to type 2 diabetes, as the increased demands on the body can reveal underlying limitations in [...]

  • London Pregnancy Clinic expands to Chelsea

    London Pregnancy Clinic has officially expanded its expert services to West London with the opening of a new location in Chelsea. This new clinic will allow the team to see more patients and continue their commitment to offering high-quality care. This expansion was driven by the increasing demand for high-quality prenatal care in West London, [...]

  • Interview: On the hunt for the earliest signs of high-risk pregnancies

    Californian biotech firm Mirvie is pioneering a new approach to high risk pregnancies, by tracking a unique molecular signal associated with a leading cause of stillbirth.  Its new platform - based on RNA, the nucleic acid present in all living cells - is the first to uncover the molecular signal for babies that are at [...]

  • Future Fertility announces breakthrough in non-invasive euploid insights

    Future Fertility has developed a significant advancement in reproductive care with the launch of Euploidy Insights. This clinically validated, non-invasive tool analyses freshly retrieved oocytes to predict which are most likely to develop into euploid blastocysts—embryos with the correct number of chromosomes—during IVF treatment. By providing these insights early in the process, Euploidy Insights is set [...]

  • Distance affects use of telehealth to access abortion pills

    The distance between a patient’s home and an abortion-services facility where they would seek care significantly influences how they receive birth-control medications, according to a new study. The research began at the start of the Covid-19 pandemic, when receiving abortion medication via telehealth and through the mail was novel, before the U.S. Supreme Court’s Dobbs [...]

  • Ultrasound scans in pregnancy: A trusted guide amid emerging MRI research

    For many born during the UK’s most common birth dates, their arrival often carries a festive backstory. Christmas holidays, time off work, and the boost to sperm quality in winter—December becomes a season of new beginnings. Fast forward nine months, and January turns into a time of fresh starts, not just for the year ahead [...]

  • Guidelines developed for managing blood cancers in pregnancy

    A new set of guidelines has been developed to assist with the diagnosis and expert management of serious blood cancers in pregnancy, with an Australian working group having published a position statement based on current evidence and expert consensus. About 12.5 pregnancies per 100,000 are affected by blood cancers such as acute leukaemia and aggressive [...]